Cingulate Inc.

NASDAQ:CING

Biotechnology

Healthcare
$5.11 -0.95%

-$0.05 today

Market cap
$76.46M
Beta
-0.91
P/E (TTM)
-1.0
EPS (TTM)
-$5.10
52W Low $3.16High $11.89

Volume 0.95M

Average 0.46M

Balance Sheet

Inspect the capital base behind the business.

Assets

$15.07M

FY 2025 · Annual

+1.4% YoY

Liabilities

$12.56M

FY 2025 · Annual

+69.6% YoY

Equity

$2.51M

FY 2025 · Annual

-66.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents16.49M5.36M52.42K12.21M10.95M
Short-term Investments9330000
Net Receivables690.25K234.43K14.62K26.33K8.01K
Inventory0100.34K000
Other Current Assets1.7M1.64M490.86K368.29K80.08K
Total Current Assets18.88M7.87M578.59K12.66M12.01M
Property, Plant & Equipment (Net)4M3.54M2.91M2.2M3.07M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets1.36B5.91B000
Other Non-current Assets(1.36B)(5.91B)000
Total Non-current Assets4M3.54M2.91M2.2M3.07M
Total Assets22.89M11.41M3.49M14.86M15.07M
Account Payables264.69K762.36K5.2M1.27M2.04M
Short-term Debt310.69K5M3M2.53M6.3M
Tax Payables00120.57K200K0
Deferred Revenue601.3K0000
Other Current Liabilities(336.67K)719.01K593.02K355.48K455.18K
Total Current Liabilities1.18M7.01M10.23M4.97M10.31M
Long-term Debt0002.44M1.15M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities866.04K510.24K135.1K2.44M2.25M
Total Liabilities2.04M7.52M10.36M7.41M12.56M
Common Stock1.13K6110340725
Retained Earnings(51.73M)(69.41M)(92.94M)(108.49M)(132.38M)
Accumulated OCI1650000
Other Stockholders Equity00000
Minority Interest00000
Total Equity20.84M3.88M(6.87M)7.46M2.51M
Total Debt1.19M5.87M3.51M5.1M8.79M
Net Debt(15.3M)509.77K3.46M(7.11M)(2.17M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$25.9M
Receivables$53.9K
Other Current$2.0M
Total Current Assets$27.9M
PP&E (Net)$2.9M
Total Non-current Assets$2.9M
Total Assets$30.9M

Analysis

Selected assets total $30.9M for Latest. The largest visible component is Cash & Equivalents at $25.9M, about 83.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
424B3424B3 filingNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 2, 2026

How much cash does CING have?

Cingulate Inc. (CING) reported $10.95M in cash and equivalents in fiscal 2025.

How much debt does CING carry?

Cingulate Inc. (CING) reported $8.79M of total debt, with net debt of -$2.17M.